INTERVENTION IN CHD WHEN AND
|
|
- Kelly Carr
- 5 years ago
- Views:
Transcription
1 SCENARIO OF CARDIOVSCILAR DISEASE IN NEPAL INTERVENTION IN CHD WHEN AND HOW DR. YADAV BHATT MBBS, MD (Med) DM (Cardiology) DNB Fellow in Interventional Cardiology MBBS, (Escorts heart MD institute) (Med) DR. YADAV BHATT DM (Cardiology) CARDIOLOGIST DNB GANGALAL Interventional NATIONAL HEART Cardiology CENTER (Escorts Heart Institute) PROFESSOR CARDIOLOGY NATIONAL ACADEMY OF MEDICAL SCIENCES GANGALA NATIONAL HEART CENTER CHIEF OF CATH LAB, NORVIC ESCORTS INTERNATIONAL HOSPITAL
2 SCENARIO OF CARDIOVASCULAR DISEASE IN NEPAL CHINA INDIA
3 Area: sq. kilometers Population: 27,000,000
4 CHINA HILLS HIMALAYAS INDIA TARAI NEPAL IS CLEARLY DEMARCATED INTO THREE REGIONS
5
6 THE HIMALAYA REGION
7 THE HILLS
8
9 International & domestic airports International flight connections ACCESSIBILITIES 13 online carriers:thai Airways, Austrian Air, Indian Airlines, Jet Airways, Sahara Air, China Southwest Airlines, Druk Airlines, Gulf Air, Qatar Airways, PIA, RNAC, Cosmic Air, Air Nepal Catering Services to:20 major international cities including Mumbai, Bangkok, New Delhi, Singapore, Hong Kong, Kolkata, Dubai, Shanghai, Osaka, Dhaka, Karachi, Thimpu, Abu dhabi, Varanasi, Kuala Lampur 22 Direct flights per week from Europe 15 Direct flights per week from middle east 24 Direct flights per week from far east 53 Direct flights per week from south asia 8-10 flights from china/week Adequate local ground transportation
10 Cardiovascular disease has become ubiquitous cause of morbidity and mortality
11 TRAGEDY WITH CVD ACCORDING TO WHO 30% OF GLOBAL DEATH IN 1998 DUE TO CVD = 15.3 MILLION LIVES LOST THAT YEAR LOW AND MIDDLE INCOME COUNTRIES CONTRIBUTED 78% OF DEATHS
12 SAHID GANGALAL NATIONAL HEART CENTER 80000/ year
13 CARDIOVASCULAR RISK FACTORS Tobacco consumption Year Place Population Prevalence Remarks 1983 Kathmandu (urban) >20,both sex 37 Current 1983 Kathmandu (rural) >20,both sex 68.4 Current 1983 Parsauni (Terai, rural) >20,both sex 54.7 Current 1983 Jumla (mountain, rural) >20,both sex 77.7 Current 1999 Dharan (East Nepal, urban) College students 24.8 Current 2001 Dharan (East Nepal, urban) >35 years, females 30.3 Current 2001 Dharan (East Nepal, urban) >35 years, females 16.5 Smokeles s 2004 Dharan (East Nepal, urban) >35 years, males 74 Current/e x Pandey MR. Hypertension in Nepal. Mrigendra Medical Trust Niraula SR. Tobacco Use among Women in Dharan, Eastern Nepal. J Health Popul Nutr 2004;22(1):68-74 Jha N et al. Prevalence of tobacco use among college students of Dharan, eastern Nepal. Nepal Journal of Science and Technology 2002; 4: Research report on NCD risk factors surveillance in Nepal, 2003 Vaidya A et al.prevalence of Coronary Heart Disease in the Urban Adult Males of Eastern Nepal: A populationbased analytical cross-sectional study 13
14 CARDIOVASCULAR RISK FACTORS Diabetes mellitus Year Place Age Prevalence % 2005 Dharan (East Nepal, urban) >35 years, males Kathmandu (urban) >40,both sex 19.0
15 CARDIOVASCULAR RISK FACTORS Hypertension Year Place 1983 Kathmandu (urban) 1983 Kathmandu (rural) 1983 Parsauni (Terai, rural) 1983 Jumla (mountain, rural) 1998 Kathmandu (low altitude) Khumbu (high altitude) 2004 Dharan (East Nepal, urban) Population Prevalence % >20,both sex 9.98 >20,both sex 5.98 >20,both sex 8.11 >20,both sex 5.30 Sherpa, men >35 years, males Kathmandu >18 Men Female Overall Pandey MR. Hypertension in Nepal. Mrigendra Medical Trust Research report on NCD risk factors surveillance in Nepal, 2003 Vaidya A, et al. Exploring the iceberg of hypertension: A community based study in an Eastern Nepal town. KUMJ (2007), 5(3): Shrestha UKet al. 15
16 HYPERTENSION STUDY NUMBER 1114 ( 2005) MEN 541 FEMALE 573 AGE YEARS MEAN 37.8 ±16.3
17 HYPERTENSION PREVALENCE OF HTN 22.2% IN MEN 17.3% IN WOMEN OVERALL PREVALENCE 19.7% AGE DISTRIBUTION 4.1% < 30 YEARS >40% IN > 50YEARS
18 PREVALENCE OF HYPERTENSION AGE DISTRIBUTION AGE GROUP HTN SUBJECTS TOTAL NUMBER PREVALEN CE % < >
19 HTN JNC VII CATEGORY NUMBER PERCENTAGE NORMAL PRE- HTN HTN
20 HTN AWARENESS 44.7% ASYMPTOMATIC 55% SYMPTOMATIC 76% HEADACHE 48.8% DIZZINESS 58.9% UNAWARE OF THEIR HTN 41.1% AWARE OF THEIR HTN
21 CHANGING TREND IN HTN STUDY IN 1981: PREVALENCE 5.98% (WHO 1978 CRITERIA ± 165/95) LATEST 2005 STUDY (SAME CRITERIA) PREVALENCE WOULD BE 11%
22 EXPLORING THE ICEBURG OF HTN Diagnosed and controlled (34.01%) Diagnosed and uncontrolled (24.13%) Undiagnosed (41.86%)
23 CARDIOVASCULAR RISK FACTORS LIPIDS mg% NAKANISHI 1997 KARKI 2004 LIMBU 2008 TC 152± ± 184± TG 121± ± ±88.7 HDL 28± ± ±11.7 LDL 84.97± ±42.0
24 CARDIOVASCULAR RISK FACTORS SEDENTARY LIFESTYLE < 10 mins of walk / day No physical activity Job, leasure time, house hold 4 days a week Broca s index-ht in cm 100 Smokeless--- khaini etc
25 CARDIOVASCULAR RISK FACTORS METAB0LIC SYNDROME IN INDIA 1/3 rd URBAN POPULATION HAVE METABOLIC SYNDROME ONSET AT AGE MENIFESTATION YEARS LATER Ie. AT AGE YEARS
26 CARDIOVASCULAR RISK FACTORS Obesity Year Place Kathmandu (urban) 1983 Kathmandu (rural) 1983 Parsauni (Terai, rural) 1983 Jumla (mountain, rural) 2004 Dharan (East Nepal, urban) 2004 Dharan (East Nepal, urban) Population Prevalence Remarks >20,both sex 24.3 Broca s Index >20,both sex 12 Broca s Index >20,both sex 9.2 Broca s Index >20,both sex 8.3 Broca s Index >35 years, males 40.1 BMI >35 years, males 51.2 WHR Sedentary lifestyle Year Place Population Prevalence Remarks 2003 National 18-69, both sex Kathmandu (urban) 25-64, both sex Dharan(East Nepal, urban) >35 years, males 44.1 Pandey MR. Hypertension in Nepal. Mrigendra Medical Trust Vaidya A et al. Association of Obesity and Physical Activity in Adult Males of Dharan, Nepal. KUMJ 2006; 4(2): World Health Organization. World Health Survey, Nepal. Research report on NCD risk factors surveillance in Nepal,
27 Prevalence of Metabolic Syndrome MALES 16.9% FEMALES 8.7 % TOTAL 12.4 Sharma D at al, NHJ 2009
28 RISK FACTORS in CAD PATIENTTS SMOKING 82% HTN 40% DAIBETES 22% HLP 25%
29 METABOLIC SYNDROME CRITERIA AHA / NHBLI 1. WAIST CIRC: >= 90 cm male >= 80 cm female 2. TG >= 150 mg% 3. HDL <= 40 mg% male <= 50 mg female 4. BP >= 130 mmhg >= 85 mmhg 5 BLOOD SUGAR >= 100 mg % (F)
30 CARDIOVASCULAR DISEASES Nepalese in general have poor knowledge of CV health Limbu YR, et al. Public knowledge of heart attack in a Nepalese population Survey. Journal of Acute & Critical Care. 2006; 35(3):
31 RHEUMATIC HEART DISEASE PREVALENCE RHD: 1.2/1000
32
33
34 PATTERN OF VALVULAR INVOLVEMENT IN RHD N= 9521 RHD CASES MALES ( 40.6%) 5654 FEMALES (50.4%)
35 RHD - VALVULAR INVOLVEMENT MS/ MR 16.7% MR 16.1% MS 15.5% MR/AR 12.1% MR/MS/AR 11.8% AV 4.21% MV INVOLVEMENT 95.79% VALVULAR INVOLVEMENT 7.2%
36 RHD INTERVENTIONS 400 PERCUTANEOUS MITRAL VALVOTOMIES LAST YEAR 1300 SURGERIES DONE LAST YEAR 30% WERE RHD CASES
37 CONGESTIVE HEART FAILURE BECOMING COMMONEST DISEASE IN THE WORLD SAME TREND IN OUR COUNTRY
38 ADMISSION IN INTENSIVE CARE 8% 20% 13% 5% RHD 28% DCM VHD IHD Arrhy ACS 18% 8% HTN
39 ADMISSION IN INTENSIVE CARE 20% 5% CHF IHD Arrhy 8% 13% 54% ACS HTN
40 CORONARY ARTERY DISEASE Population studies indicate high CHD burden Population-based Estimation of Prevalence of CHD in Nepal Year Place Prevalence 1997 Kathmandu (urban) Dharan (urban) 5.7 ( ) Shrestha UK et al. (Personal communication) Vaidya A et al.prevalence of Coronary Heart Disease in the Urban Adult Males of Eastern Nepal: A population-based analytical cross-sectional study 40
41 CORONARY ARTERY DISEASE Among hospital admissions CAD 21.7% MALES 74% FEMALES 26%
42 RISK FACTORS in CAD PATIENTTS SMOKING 82% HTN 40% DAIBETES 22% HLP 25%
43 RISK FACTORS in CAD PATIENTS 22 % 25 SMOKING 82 HTN HLP DIABETES 40
44 TRENDS IN CAD YOUNGER POPULATION NO PREVIOUS ANGINA INFERIOR MI FREQUENT CAUSE OF DEATH
45 CONGENITAL HEART DISEASE CONGENITAL HEART DISEASE PREVALENCE 1.3/1000 COMMONEST LESION ATRIAL SEPTAL DEFECT VENTRICULAR SEPTAL DEFECT
46 CATH LAB PROCEDURES 3000 CASES/ YEAR 10% 9% 9% 5% 2% CAG PTMC PTCA 51% RHC PACING EP/RFA 14% OTHERS
47 CARDIOVASCULAR SURGERY 1300/ YEAR 17% 5% 39% Congenital valvular CABG 9% Vascular others 30%
48 WHAT ARE WE DOING Where advanced health care service is in accessible.
49 RHD FREE PENICILLINE PROPHYLAXIS
50
51
52
53
54 Problems Lack of adequate research on risk factors and other aspects on CVD Lack of intermediate-level manpower No national policy/programme on CV diseases Centralization of specialist heart care CVD not included in primary health care system Cost of intervention/surgery unaffordable Insufficient emphasis on preventive measures
55 THANK YOU
Non communicable Diseases
Non communicable Diseases Vision, Goals and Challenges Where we are in Palestine? Dr. Johny R. Khoury Consultant Cardiologist Medical Relief Prevention and Diagnostic Center of cardiovascular diseases
More informationKnowledge and practice regarding prevention of myocardial infarction among visitors of Sahid Gangalal national heart center, Kathmandu, Nepal
RESEARCH ARTICLE Diabetes Management Knowledge and practice regarding prevention of myocardial infarction among visitors of Sahid Gangalal national heart center, Kathmandu, Nepal Punam Dahal* & Rekha Karki
More informationRheumatic Heart Disease Revisited: Patterns of Valvular Involvement from a Consecutive Cohort in Eastern Nepal
Rheumatic Heart Disease Revisited: Patterns of Valvular Involvement from a Consecutive Cohort in Eastern Nepal Shrestha NR1, Pilgrim T2, Karki P1, Bhandari R1, Basnet S1, Tiwari S1, Urban P3. Dr. Nikesh
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationInternational Journal of Basic and Applied Physiology
Cardiovascular Health Screening Of A Of Adults Residing In Ahmedabad City A Study Of Correlation Between Exercise, Body Mass Index And Heart Rate Jadeja Upasanaba*, Naik Shobha**, Jadeja Dhruvkumar***,
More informationThe Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine
The Burden of Heart Failure in the Asia Pacific Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine Q1. The most prevalent risk factor for heart failure in the
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationPrevalence of Cardiac Risk Factors among People Attending an Exhibition
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 3, Issue 6 Ver. IV (Nov.-Dec. 2014), PP 4-51 Prevalence of Cardiac Risk Factors among People Attending
More informationPrevalance of Lifestyle Associated Risk Factor for Non- Communicable Diseases among Young Male Population in Urban Slum Area At Mayapuri, New Delhi
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 7 Ver. 17 (July. 2018), PP 59-64 www.iosrjournals.org Prevalance of Lifestyle Associated Risk
More informationPrevalence of Hypertension in Semi-Urban area of Nepal
ORIGINAL ARTICLE Prevalence of Hypertension in Semi-Urban area of Nepal Koju R*, Manandhar K*, Gurung R*, Pant P*, Bedi TRS* *Department of Internal Medicine, Dhulikhel Hospital KUH ABSTRACT Hypertension
More informationIschemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary Care Unit Patients
Ischemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary (MBCHB, DM, FICMS) 1 Abstract Background: Ischemic heart disease (IHD) is the commonest type of heart disease.it causes more deaths
More informationState of Cardiovascular Health in the NT DR MARCUS ILTON
State of Cardiovascular Health in the NT DR MARCUS ILTON Background NT Population For whom we provide Cardiac Care Population - 250,000 Darwin - 140,000 Alice Springs - 40,000 Katherine - 10,000 Tennant
More informationPOST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015
No. of Printed Pages : 20 MCC-006 POST GRADUATE DIPLOMA IN CLINICAL 0 CARDIOLOGY (PGDCC) Term-End Examination June, 2015 MCC-006 : CARDIO VASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note :
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationEXS 145 Guidelines for Exercise Testing & Prescription
EXS 145 Guidelines for Exercise Testing & Prescription 11-3-11 Andrew Weiler M.Ed MCCD Adjunct Faculty CGCC Employee Wellness Coordinator SRPMIC Employee Wellness Coordinator Pot & Window LLC Today How
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationLife Science Journal 2018;15(12)
Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,
More informationEconomically efficient approaches to address chronic disease in developing countries
Economically efficient approaches to address chronic disease in developing countries Thomas A. Gaziano MD MSc Division of Cardiovascular Medicine Brigham & Women s Hospital Harvard Medical School Center
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationMyths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!
Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the
More informationASIA-PACIFIC HEART HEALTH CHARTER
ASIA-PACIFIC HEART HEALTH CHARTER The Asia-Pacific Heart Health Charter has been developed by the Asia-Pacific Heart Network in collaboration with Asia Pacific Society of Cardiology to help stem the growing
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationStudy of clinical presentations of acute myocardial infarction in Indian Population
Original article: Study of clinical presentations of acute myocardial infarction in Indian Population *Dr Aakash R Badgujar, **Dr Vijay K Joglekar *Department of Medicine, GMC, Mumbai **Head of Department,
More informationDavid A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio
1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,
More informationHow do we define ethnic healthcare disparities? Ethnic Disparity. Cardiovascular Disease in Asians: Are Asians at Increased Risk?
Cardiovascular Disease in Asians: Are Asians at Increased Risk? November 17, 2007 Gordon L. Fung, MD, MPH, PhD, FACC, FAHA, FACP Director, Asian Heart & Vascular Center Clinical Professor of Medicine UCSF
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More information5. Cardiovascular Disease & Stroke
5. Cardiovascular Disease & Stroke 64: Self-Reported Heart Disease 66: Heart Disease Management 68: Heart Disease Mortality 70: Heart Disease Mortality Across Life Span 72: Stroke Mortality 185: Map 3:
More informationCardiovascular Disease in Women -Vive La Difference? Dr Homeyra Douglas Consultant Cardiologist Aintree University Hospital
Cardiovascular Disease in Women -Vive La Difference? Dr Homeyra Douglas Consultant Cardiologist Aintree University Hospital Death By Cause - Women 2004 UK Death by Cause-Women 2004 UK -CVD is responsible
More informationPrediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal
Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationMohammad Zubaid, MB, ChB, FRCPC, FACC
Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Mohammad Zubaid, MB, ChB, FRCPC, FACC
More informationHeart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing
EXAMING HEART FAILURE: HOW TO RECOGNIZE AND TREAT THE WEAK HEART What is Heart Failure? Treatment of Heart Failure End Stage Heart Failure Munir S. Janmohamed M.D. FACC Assistant Clinical Professor of
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationDr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System MFMER slide-1
Dr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System 2011 MFMER slide-1 Heart Disease in Women and Why we are concerned 6,600,000 US women >440,000
More informationUnderstanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s
Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based
More information40% minimum reduction from
160 Circulatory Disease Mortality Target: Death rates in England 1993-2006 Persons under 75 Death / 100,000 population A fall of 44% over 10 years 140 120 100 80 60 40 20 141.0 84.2 Immortality guaranteed
More informationTennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center
Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationLipid Management 2013 Statin Benefit Groups
Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationHeart Disease in Women. Charlotte A. Lee, M.D., DBIM, FLMI
Heart Disease in Women Charlotte A. Lee, M.D., DBIM, FLMI Heart Disease in Women Congenital Heart Disease Valvular Heart Disease Arrhythmias Cardiomyopathy Hypertension Coronary Artery Disease Coronary
More informationLeft Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient
Left Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient Dr. Peersab.M. Pinjar 1, Dr Praveenkumar Devarbahvi 1 and Dr Vasudeva Murthy.C.R 2, Dr.S.S.Bhat 1, Dr.Jayaraj S G 1
More informationDECLARATION OF CONFLICT OF INTEREST. none
DECLARATION OF CONFLICT OF INTEREST none Hypertension and Type 2 Diabetes in The Arab Countries M B BDEIR, MD Director, Cardiac Clinics King Abdulaziz Cardiac Centre, National Guard Health Affairs Riyadh,
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationLifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study
Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationDECLARATION OF CONFLICT OF INTEREST. None
DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationContra-indications, Risks, and Safety Precautions for Stress Testing. ACSM guidelines, pg 20 7 ACSM RISK FACTORS. Risk Classifications pg 27
Contra-indications, Risks, and Safety Precautions for Stress Testing Data to Support Stress Testing How safe is stress testing? Contra-indications Termination Criteria Ellstad Chapt 5 ACSM Chapts 3-6 Seattle
More informationAn Epidemiological Study of Hypertension and Its Risk Factors in Rural Population of Bangalore Rural District
AJMS Al Ameen J Med Sci (2 012 )5 (3 ):2 6 4-2 7 0 (A US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 C O D E N : A A J M B G ORIGI NAL ARTICLE An Epidemiological Study of Hypertension
More informationManagement of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018
Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationDr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)
Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton Dr Joan Leighton General Practitioner Heart Foundation Christchurch 14:00-14:55 WS #106: Whats
More informationEXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION
1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationCoronary Artery Disease in Women
Coronary Artery Disease in Women by Wael Almahmeed MD, FCCP, FRCPC, FRCPE, FACP, FACC, FESC Clinical Associate Professor of Medicine, UAE University Consultant Cardiologist at Cleveland Clinic, Abu Dhabi
More informationBridging health promotion intervention policy with behavioral risk factor surveillance in Thailand
Bridging health promotion intervention policy with behavioral risk factor surveillance in Thailand The 7 th World Alliance for Risk Factor Surveillance (WARFS) Global Conference Toronto, Ontario, Canada,
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationPlacebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationStudy of fixed dose combination for the management of cardiovascular diseases
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-331; ISSN (Online): 2321-386 Available online at: http://www.wjpsonline.org/ Original Article Study of fixed dose combination for the management
More informationDr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York
Dr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York 500,000 400,000 398,563 432,709 Deaths 300,000 200,000 290,069 269,819 100,000 78,941 59,260 36,006 65,323 51,281 42,658
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationCardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging
Cardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging A D V I C E F O R H I G H V A L U E C A R E F R O M T H E A M E R I C A N C O L L E G E O F P H Y S
More informationTrends In CVD, Related Risk Factors, Prevention and Control In China
Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationWhat s new in cardiovascular disease risk assessment and management for primary care clinicians
Cardiovascular system What s new in cardiovascular disease risk assessment and management for primary care clinicians The recently released 2018 Cardiovascular Disease Risk Assessment and Management for
More informationDownloaded from:
Annemans, L; Danchin, N; Van de Werf, F; Pocock, S; Licour, M; Medina, J; Bueno, H (2016) Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis
More informationNational Health & Morbidity Survey 2015; NCD Risk Factors
Ministry of Health Malaysia National Health & Morbidity Survey 2015; NCD Risk Factors ZALMA ABDUL RAZAK Nutrition Division Ministry of Health Malaysia 2 Introduction The National Health and Morbidity Survey
More informationPre-Operative Services Teaching Rounds 3 Jan 2011
Pre-Operative Services Teaching Rounds 3 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationMethods. OR and PAR both presented with 99% confidence intervals. All analyses adjusted for age, sex and region.
INTERHEART: Aims 1. To evaluate the association (odds ratio) of risk factors for MI globally, and in each region; and among major ethnic groups in the world. 2. To quantify the impact of each risk factor
More informationCase Studies in T2DM A Comprehensive Management Approach
Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.
More informationFREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN
ORIGINAL ARTICLE Pak Heart J FREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN 1 3 4 Muhammad Asif Iqbal, Ikramullah, Abdul Hadi, Muhammad Farooq,
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationHeart Outcomes Prevention Evaluation (HOPE) - 3 Combined Lipid Lowering and Blood Pressure Lowering in Moderate Risk People
November September 23, 20, 20102012 Heart Outcomes Prevention Evaluation (HOPE) - 3 Combined Lipid Lowering and Blood Pressure Lowering in Moderate Risk People Eva Lonn, Jackie Bosch, Jane Castelli, Andrea
More informationMiddle East Perspective on Burden of CVD. Hani Najm, MD, Msc, FACC Vice President of Saudi Heart Association
Middle East Perspective on Burden of CVD Hani Najm, MD, Msc, FACC Vice President of Saudi Heart Association Middle East Region Demographics 14 countries Population : 330 million Some of the richest & some
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationComprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium
Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationDiabetes and Chronic Diseases Preventing the Preventables
Diabetes and Chronic Diseases Preventing the Preventables Juliana CN Chan Professor of Medicine and Therapeutics On behalf of the CUHK-PWH Diabetes Care and Research Team General outline Burden of diabetes
More informationPREVALENCE OF CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH VARIOUS RISK FACTORS IN RURAL AREA OF NAGPUR
ORIGINAL ARTICLE pissn 0976 3325 eissn 2229 6816 Open Access Article www.njcmindia.org PREVALENCE OF CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH VARIOUS RISK FACTORS IN RURAL AREA OF NAGPUR Umesh
More informationCardiovascular Disease the global virus
NCS 2013 Cardiovascular Disease the global virus Dr Justin Zaman BSc MBBS MRCP MSc PhD Consultant Cardiologist, James Paget University Hospital, Norfolk, UK Honorary Senior Lecturer, University of East
More informationPrevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary Health Care in Bahrain
Prevalence of Diabetes Mellitus among Non-Bahraini Workers Page 1 of 10 Bahrain Medical Bulletin, Vol.25, No.1, March 2003 Prevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary
More informationInternational model for prevention of chronic disease: Finland experience
International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project
More informationCase Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas
Case Presentation Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas Izzy (2006) 51 y/o Hispanic woman with a history of diabetes and obesity. Her diabetes
More informationObjectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009
Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More informationTransitions in Mortality from Cardiovascular Disease in Hong Kong, Shanghai and Taipei City:
Transitions in Mortality from Cardiovascular Disease in Hong Kong, Shanghai and Taipei City: Trends, Patterns, and Contribution to Improvement of Life Expectancy Jiaying Zhao (1), Zhongwei Zhao (1), Jow
More information